Overnight home use of artificial pancreas 'feasible and beneficial'

Credit: Alisha Vargas

(Medical Xpress)—Children with type 1 diabetes have been able to use pioneering artificial pancreas technology, developed at the University of Cambridge, for the first time overnight at home without the supervision of researchers.

The promises to dramatically improve the quality of life for people with type 1 , which typically develops in childhood. All previous artificial pancreas trials, in hospitals and in home environments, have seen researchers strictly monitor patients. The latest trial, funded by JDRF, has shown for the first time that unsupervised use of the artificial pancreas overnight can be safe. The results of the trial are published today in the journal Diabetes Care.

Type 1 diabetes is an autoimmune condition in which the pancreas is unable to produce insulin, a hormone which regulates levels. High levels of glucose can seriously damage the body's organs. People with type 1 diabetes currently rely on multiple insulin injections or pump infusions every day; a child diagnosed at the age of five faces up to 19,000 injections and 50,000 finger prick blood tests by the time they are 18.

Participants in the trial, all aged between 12 and 18, saw improved blood glucose control during the trial, experiencing fewer nights with hypoglycaemic episodes, generally known as 'hypos'. A hypo occurs when the of someone living with type 1 diabetes falls dangerously low. Without proper treatment, it may cause unconsciousness and even death.

A real-time information haul of more than 10,000 UK residents with type 1 diabetes, released to JDRF from the mySugr app, suggests that UK people living with the condition experience an average of ten hypos per week.

Actor Jeremy Irvine, star of the Stephen Spielberg film War Horse, has lived with type 1 diabetes since the age of six. He said: "When the chance came for me to take part in early artificial pancreas trials a few years ago, I jumped at the opportunity. I wanted to play my own very small part in moving the artificial pancreas closer to reality. I'm really excited to hear of this latest progress – the scientists behind it are my heroes."

Dr Roman Hovorka from the University of Cambridge, who is leading the UK effort to develop an effective artificial pancreas, said: "The study is an important stepping stone for the wider use of an artificial pancreas. We have shown that overnight home use is feasible and beneficial – allowing people to live their life more freely.

"The artificial pancreas is expected to transform the treatment of type 1 diabetes and we have proven that this promise holds. The success of this trial means that larger and longer studies are already in the pipeline."

Katharine Barnard, from the Human Development and Health Academic Unit at the University of Southampton, worked with Dr Hovorka on the trial to evaluate psychosocial impact. She said: "Hypoglycaemia – particularly at night – is a common fear among those living with and a major obstacle in achieving optimal blood glucose levels. The findings from this study are positive and are certainly worth investigating further.

"Reassurance, confidence and improved diabetes control are just some of the psychological and physical benefits that patients may witness as artificial pancreas technology continues to develop."

More information: Roman Hovorka, Daniela Elleri, Hood Thabit, Janet M. Allen, Lalantha Leelarathna, Ranna El-Khairi, Kavita Kumareswaran, Karen Caldwell, Peter Calhoun, Craig Kollman, Helen R. Murphy, Carlo L. Acerini, Malgorzata E. Wilinska, Marianna Nodale, and David B. Dunger. "Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial." Diabetes Care May 2014 37:5 1204-1211; DOI: 10.2337/dc13-2644 1935-5548

add to favorites email to friend print save as pdf

Related Stories

Model predicts blood glucose levels 30 minutes later

Mar 25, 2014

A mathematical model created by Penn State researchers can predict with more than 90 percent accuracy the blood glucose levels of individuals with type 1 diabetes up to 30 minutes in advance of imminent changes in their levels—plenty ...

Recommended for you

Screening for diabetes at dental visits using oral blood

16 hours ago

It is estimated that 8.1 million of the 29.1 million Americans living with diabetes are undiagnosed and many who have diabetes have poor glycemic control. Given that each year many Americans visit a dental provider but not ...

CBT, sertraline insufficient in diabetes and depression

17 hours ago

(HealthDay)—For patients with diabetes and depression, improvements in depression are seen with cognitive behavioral therapy (CBT) or sertraline, with a significant advantage for sertraline, but glycemic ...

Early signs in young children predict type 1 diabetes

22 hours ago

New research shows that it is possible to predict the development of type 1 diabetes. By measuring the presence of autoantibodies in the blood, it is possible to detect whether the immune system has begun to break down the ...

Daily menu plan reduces blood sugar significantly

Feb 25, 2015

A large group of people with diabetes who followed a menu plan created by University of Alberta nutrition researchers for just three months significantly reduced their blood sugar levels.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.